Additionally, AgNP administration also induced increased mRNA expression of Srebp-1c, Fasn, Acc1, and Scd1 in NAFLD mice, resulting in an enhanced hepatic steatosis and lipid accumulation. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.